Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes.

Chu, C-H; Lee, J-K; Lam, H-C; Lu, C-C; Sun, C-C; Wang, M-C; Chuang, M J; Wei, M-C

Chu, C-H; Lee, J-K; Lam, H-C; Lu, C-C; Sun, C-C; Wang, M-C; Chuang, M J; Wei, M-C.

Affiliation

Chu CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan. chchu@isca.vghks.gov.tw

J Endocrinol Invest ; 31(1): 42-7, 2008 Jan.

Article in En | MEDLINE | ID: mdl-18296904

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Insulin Resistance / Leptin / Diabetes Mellitus, Type 2 / Adiponectin / Heptanoic Acids / Hyperlipidemias Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Endocrinol Invest Year: 2008 Document type: Article Affiliation country: Taiwán Country of publication: Italia

Search on Google

Add to My VHL

XML

PubMed Links